Lonza expands Houston laboratory for exosome production

From Houston Business Journals

A European biotech company with a significant Houston presence is adding to its local footprint with a laboratory expansion.

Switzerland-based contract development and manufacturing organization Lonza Group Ltd. announced the completion of 15,000 square feet of laboratory space on Feb. 2. Behnam Ahmadian Baghbaderani, Lonza’s head of process development for cell and gene therapy, said the space would allow Lonza to host more customers looking to manufacture cell and gene therapy as well as to expand offerings to new treatments involving exosomes, which could allow human bodies to regenerate.